Literature DB >> 2014983

Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells.

F Bellido1, J C Pechère, R E Hancock.   

Abstract

The ability of five new beta-lactams to permeate the outer membrane of intact Enterobacter cloacae beta-lactamase-overproducing cells was measured by using a high-pressure liquid chromatography (HPLC)-based technique that avoided certain possible artifacts of the traditional methods. Low concentrations of antibiotics were mixed with bacterial suspensions, and at different times, the cells were removed from the medium by filtration. Residual beta-lactam concentrations in the medium were then assessed by HPLC and UV detection. The assay was performed under conditions in which no beta-lactamase activity was detected in the filtrate and the number of viable cells remained constant during the experiment. Outer membrane permeability was assessed with the Zimmermann-Rosselet equation, in which outer membrane permeability was rate limiting for hydrolysis of the beta-lactam by periplasmic beta-lactamase. Thus, the rate of disappearance of beta-lactam was equal to the rate of outer membrane permeation. Preincubation of bacterial suspensions with 300 micrograms of cloxacillin per ml inhibited the hydrolysis of beta-lactams by intact cells, demonstrating that beta-lactam hydrolysis by periplasmic beta-lactamase was essential in order to allow measurement of outer membrane permeability by this method. Permeability coefficients (P) were calculated from the Zimmermann-Rosselet equation and were independent of the external concentration of antibiotic over a 100-fold concentration range. Cefepime and cefpirome exhibited rates of outer membrane permeation 5- to 20-fold higher than those of carumonam, ceftriaxone, and cefotaxime. Thus, the presence of a positive charge in the 3-lateral chain increased the permeation ability of beta-lactam molecules considerably.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014983      PMCID: PMC244943          DOI: 10.1128/AAC.35.1.68

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  The interplay of beta-lactamases and intrinsic factors in the resistance of gram-negative bacteria to penicillins and cephalosporins.

Authors:  M H Richmond; N A Curtis
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

2.  Effect of EDTA upon bacterial permeability to benzylpenicillin.

Authors:  J M Hamilton-Miller
Journal:  Biochem Biophys Res Commun       Date:  1965-09-22       Impact factor: 3.575

3.  Outer membrane of Salmonella typhimurium: chemical analysis and freeze-fracture studies with lipopolysaccharide mutants.

Authors:  J Smit; Y Kamio; H Nikaido
Journal:  J Bacteriol       Date:  1975-11       Impact factor: 3.490

Review 4.  Penicillin-binding proteins and the future of beta-lactam antibiotics. The Seventh Fleming Lecture.

Authors:  B G Spratt
Journal:  J Gen Microbiol       Date:  1983-05

5.  Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins.

Authors:  H Nikaido; E Y Rosenberg
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

6.  A method for measuring the outer membrane-permeability of beta-lactam antibiotics in gram-negative bacteria.

Authors:  T Sawai; K Matsuba; S Yamagishi
Journal:  J Antibiot (Tokyo)       Date:  1977-12       Impact factor: 2.649

7.  Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae.

Authors:  F Bellido; J C Pechère; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

8.  Porin channels in Escherichia coli: studies with beta-lactams in intact cells.

Authors:  H Nikaido; E Y Rosenberg; J Foulds
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

9.  Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.

Authors:  W Zimmermann; A Rosselet
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

10.  A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics.

Authors:  H Kojo; Y Shigi; M Nishida
Journal:  J Antibiot (Tokyo)       Date:  1980-03       Impact factor: 2.649

View more
  15 in total

Review 1.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Authors:  Markus Mueller; Amparo de la Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model.

Authors:  D M Cappelletty
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 3.  β-Lactams and β-Lactamase Inhibitors: An Overview.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

Review 4.  Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.

Authors:  L R Wiseman; H M Lamb
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

5.  Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae.

Authors:  F Bellido; J C Pechère; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 6.  Cefepime clinical pharmacokinetics.

Authors:  M P Okamoto; R K Nakahiro; A Chin; A Bedikian
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

7.  Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.

Authors:  M J Pucci; J Boice-Sowek; R E Kessler; T J Dougherty
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

8.  Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.

Authors:  M Picard; F Malouin
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

9.  Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance.

Authors:  X Z Li; D Ma; D M Livermore; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

Review 10.  Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  L B Barradell; H M Bryson
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.